{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:38:42Z","timestamp":1794670722743,"version":"4.9.1"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is increasing evidence that prolactin (PRL), a hormone\/cytokine, plays a role in breast, prostate, and colorectal cancers via local production or accumulation. Elevated levels of serum PRL in ovarian and endometrial cancers have been reported, indicating a potential role for PRL in endometrial and ovarian carcinogenesis. In this study, we show that serum PRL levels are significantly elevated in women with a strong family history of ovarian cancer. We show dramatically increased expression of PRL receptor in ovarian and endometrial tumors as well as in endometrial hyperplasia, signifying the importance of PRL signaling in malignant and premalignant conditions. PRL mRNA was expressed in ovarian and endometrial tumors, indicating the presence of an autocrine loop. PRL potently induced proliferation in several ovarian and endometrial cancer cell lines. Binding of PRL to its receptor was followed by rapid phosphorylation of extracellular signal-regulated kinase (ERK) 1\/2, mitogen-activated protein kinase\/ERK kinase 1, signal transducer and activator of transcription 3, CREB, ATF-2, and p53 and activation of 37 transcription factors in ovarian and endometrial carcinoma cells. PRL also activated Ras oncogene in these cells. When human immortalized normal ovarian epithelial cells were chronically exposed to PRL, a malignant transformation occurred manifested by the acquired ability of transformed cells to form clones, grow in soft agar, and form tumors in severe combined immunodeficient-beige mice. Transformation efficiency was diminished by a Ras inhibitor, providing proof that PRL-induced transformation uses the Ras pathway. In summary, we present findings that indicate an important role for PRL in ovarian and endometrial tumorigenesis. PRL may represent a risk factor for ovarian and endometrial cancers. [Cancer Res 2009;69(12):5226\u201333]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4652","type":"journal-article","created":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T21:10:49Z","timestamp":1243977049000},"page":"5226-5233","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Biological Significance of Prolactin in Gynecologic Cancers"],"prefix":"10.1158","volume":"69","author":[{"given":"Vera V.","family":"Levina","sequence":"first","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"},{"name":"2Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nolen","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YunYun","family":"Su","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Godwin","sequence":"additional","affiliation":[{"name":"6Fox Chase Cancer Center, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fishman","sequence":"additional","affiliation":[{"name":"7Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[{"name":"8M. D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Mor","sequence":"additional","affiliation":[{"name":"9Yale University School of Medicine, New Haven, Connecticut; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry G.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"10Walter Reed Army Medical Center, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Herberman","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"},{"name":"2Medicine,"},{"name":"3Pathology,"},{"name":"4Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw J.","family":"Szczepanski","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Szajnik","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elieser","family":"Gorelik","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"},{"name":"3Pathology,"},{"name":"4Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Lokshin","sequence":"additional","affiliation":[{"name":"1University of Pittsburgh Cancer Institute and Departments of"},{"name":"2Medicine,"},{"name":"3Pathology,"},{"name":"5Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,6,15]]},"reference":[{"key":"2022061700293854100_B1","doi-asserted-by":"crossref","unstructured":"Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol\u20082002; 64: 47\u201367.","DOI":"10.1146\/annurev.physiol.64.081501.131049"},{"key":"2022061700293854100_B2","doi-asserted-by":"crossref","unstructured":"Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine\/paracrine growth factor in human cancer. Trends Endocrinol Metab\u20082002; 13: 245\u201350.","DOI":"10.1016\/S1043-2760(02)00603-3"},{"key":"2022061700293854100_B3","doi-asserted-by":"crossref","unstructured":"Gerlo S, Davis JR, Mager DL, Kooijman R. Prolactin in man: a tale of two promoters. BioEssays\u20082006; 28: 1051\u20135.","DOI":"10.1002\/bies.20468"},{"key":"2022061700293854100_B4","doi-asserted-by":"crossref","unstructured":"Takahashi H, Nabeshima Y, Nabeshima Y, Ogata K, Takeuchi S. Molecular cloning and nucleotide sequence of DNA complementary to human decidual prolactin mRNA. J Biochem\u20081984; 95: 1491\u20139.","DOI":"10.1093\/oxfordjournals.jbchem.a134757"},{"key":"2022061700293854100_B5","doi-asserted-by":"crossref","unstructured":"Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus\u20082001; 10: 706\u201318.","DOI":"10.1191\/096120301717164949"},{"key":"2022061700293854100_B6","doi-asserted-by":"crossref","unstructured":"Pickett CA, Gutierrez-Hartmann A. Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways. Mol Cell Biol\u20081995; 15: 6777\u201384.","DOI":"10.1128\/MCB.15.12.6777"},{"key":"2022061700293854100_B7","doi-asserted-by":"crossref","unstructured":"Buckley AR, Putnam CW, Russell DH. Prolactin as a mammalian mitogen and tumor promoter. Adv Enzyme Regul\u20081988; 27: 371\u201391.","DOI":"10.1016\/0065-2571(88)90027-1"},{"key":"2022061700293854100_B8","doi-asserted-by":"crossref","unstructured":"Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest\u20081997; 100: 2744\u201351.","DOI":"10.1172\/JCI119820"},{"key":"2022061700293854100_B9","doi-asserted-by":"crossref","unstructured":"Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci U S A\u20081995; 92: 3650\u20137.","DOI":"10.1073\/pnas.92.9.3650"},{"key":"2022061700293854100_B10","doi-asserted-by":"crossref","unstructured":"Wang DY, De Stavola BL, Bulbrook RD, et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. Intl J Epidemiol\u20081992; 21: 214\u201321.","DOI":"10.1093\/ije\/21.2.214"},{"key":"2022061700293854100_B11","doi-asserted-by":"crossref","unstructured":"Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst\u20081999; 91: 629\u201334.","DOI":"10.1093\/jnci\/91.7.629"},{"key":"2022061700293854100_B12","doi-asserted-by":"crossref","unstructured":"Tworoger SS, Hankinson SE. Prolactin and breast cancer risk. Cancer Lett\u20082006; 243: 160\u20139.","DOI":"10.1016\/j.canlet.2006.01.032"},{"key":"2022061700293854100_B13","doi-asserted-by":"crossref","unstructured":"Stattin P, Rinaldi S, Stenman UH, et al. Plasma prolactin and prostate cancer risk: a prospective study. Int J Cancer\u20082001; 92: 463\u20135.","DOI":"10.1002\/ijc.1191"},{"key":"2022061700293854100_B14","doi-asserted-by":"crossref","unstructured":"Mor G, Visintin I, Lai Y, et al. Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A\u20082005; 102: 7677\u201382.","DOI":"10.1073\/pnas.0502178102"},{"key":"2022061700293854100_B15","doi-asserted-by":"crossref","unstructured":"Yurkovetsky Z, Ta'asan S, Skates S, et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol\u20082007; 107: 58\u201365.","DOI":"10.1016\/j.ygyno.2007.05.041"},{"key":"2022061700293854100_B16","doi-asserted-by":"crossref","unstructured":"Shaw-Bruha CM, Pirrucello SJ, Shull JD. Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Res Treat\u20081997; 44: 243\u201353.","DOI":"10.1023\/A:1005879103367"},{"key":"2022061700293854100_B17","doi-asserted-by":"crossref","unstructured":"Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production. Exp Cell Res\u20082008; 314: 1605\u201316.","DOI":"10.1016\/j.yexcr.2007.12.027"},{"key":"2022061700293854100_B18","doi-asserted-by":"crossref","unstructured":"Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia\u20082002; 39: 193\u2013206.","DOI":"10.1002\/glia.10094"},{"key":"2022061700293854100_B19","doi-asserted-by":"crossref","unstructured":"Al-Jehani RM, Jeyarajah AR, Hagen B, Hogdall EV, Oram DH, Jacobs IJ. Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis. J Natl Cancer Inst\u20081998; 90: 540\u20132.","DOI":"10.1093\/jnci\/90.7.540"},{"key":"2022061700293854100_B20","doi-asserted-by":"crossref","unstructured":"Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer. Eur J Cancer\u20081997; 33: 1572\u20137.","DOI":"10.1016\/S0959-8049(97)00154-8"},{"key":"2022061700293854100_B21","doi-asserted-by":"crossref","unstructured":"Pijnenborg JM, Dam-de Veen GC, Kisters N, et al. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer. Ann Oncol\u20082007; 18: 491\u20137.","DOI":"10.1093\/annonc\/mdl455"},{"key":"2022061700293854100_B22","doi-asserted-by":"crossref","unstructured":"Liu J, Yang G, Thompson-Lanza JA, et al. A genetically defined model for human ovarian cancer. Cancer Res\u20082004; 64: 1655\u201363.","DOI":"10.1158\/0008-5472.CAN-03-3380"},{"key":"2022061700293854100_B23","doi-asserted-by":"crossref","unstructured":"Levina VN, Nolen BM, Marrangoni AM, et al. Role of CCL11\/eotaxin-1 signaling in ovarian cancer. Clin Cancer Res\u20082009; 15: 2647\u201356.","DOI":"10.1158\/1078-0432.CCR-08-2024"},{"key":"2022061700293854100_B24","unstructured":"Krikun G, Mor G, Lockwood C. The immortalization of human endometrial cells. Methods Mol Med\u20082006; 121: 79\u201383."},{"key":"2022061700293854100_B25","doi-asserted-by":"crossref","unstructured":"Yuen BH, McMorland G, Pudek M, Cannon W. Effect of general and peridural anesthesia on the concentrations of prolactin and cortisol in maternal plasma. Am J Obstet Gynecol\u20081981; 141: 483\u20136.","DOI":"10.1016\/S0002-9378(15)33264-6"},{"key":"2022061700293854100_B26","doi-asserted-by":"crossref","unstructured":"Delitala G, Tomasi P, Virdis R. Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man. Baillieres Clin Endocrinol Metab\u20081987; 1: 391\u2013414.","DOI":"10.1016\/S0950-351X(87)80069-1"},{"key":"2022061700293854100_B27","doi-asserted-by":"crossref","unstructured":"Brooks JE, Herbert M, Walder CP, Selby C, Jeffcoate WJ. Prolactin and stress: some endocrine correlates of pre-operative anxiety. Clin Endocrinol (Oxf)\u20081986; 24: 653\u20136.","DOI":"10.1111\/j.1365-2265.1986.tb01661.x"},{"key":"2022061700293854100_B28","doi-asserted-by":"crossref","unstructured":"Struman I, Bentzien F, Lee H, et al. Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A\u20081999; 96: 1246\u201351.","DOI":"10.1073\/pnas.96.4.1246"},{"key":"2022061700293854100_B29","doi-asserted-by":"crossref","unstructured":"Canbay E, Norman M, Kilic E, Goffin V, Zachary I. Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem J\u20081997; 324: 231\u20136.","DOI":"10.1042\/bj3240231"},{"key":"2022061700293854100_B30","doi-asserted-by":"crossref","unstructured":"Maus MV, Reilly SC, Clevenger CV. Prolactin as a chemoattractant for human breast carcinoma. Endocrinology\u20081999; 140: 5447\u201350.","DOI":"10.1210\/endo.140.11.7245"},{"key":"2022061700293854100_B31","doi-asserted-by":"crossref","unstructured":"Leav I, Merk FB, Lee KF, et al. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. Am J Pathol\u20081999; 154: 863\u201370.","DOI":"10.1016\/S0002-9440(10)65333-3"},{"key":"2022061700293854100_B32","doi-asserted-by":"crossref","unstructured":"Gill S, Peston D, Vonderhaar BK, Shousha S. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol\u20082001; 54: 956\u201360.","DOI":"10.1136\/jcp.54.12.956"},{"key":"2022061700293854100_B33","doi-asserted-by":"crossref","unstructured":"Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients. Cancer\u20081985; 56: 403\u201312.","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X"},{"key":"2022061700293854100_B34","doi-asserted-by":"crossref","unstructured":"Corbacho AM, Macotela Y, Nava G, et al. Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts. FEBS Lett\u20082003; 544: 171\u20135.","DOI":"10.1016\/S0014-5793(03)00499-X"},{"key":"2022061700293854100_B35","doi-asserted-by":"crossref","unstructured":"Boyd JA, Barrett JC. Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther\u20081990; 46: 469\u201386.","DOI":"10.1016\/0163-7258(90)90028-Z"},{"key":"2022061700293854100_B36","doi-asserted-by":"crossref","unstructured":"Plotnikov A, Li Y, Tran TH, et al. Oncogene-mediated inhibition of glycogen synthase kinase 3\u03b2 impairs degradation of prolactin receptor. Cancer Res\u20082008; 68: 1354\u201361.","DOI":"10.1158\/0008-5472.CAN-07-6094"},{"key":"2022061700293854100_B37","doi-asserted-by":"crossref","unstructured":"Brisken C, Ayyannan A, Nguyen C, et al. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell\u20082002; 3: 877\u201387.","DOI":"10.1016\/S1534-5807(02)00365-9"},{"key":"2022061700293854100_B38","doi-asserted-by":"crossref","unstructured":"Castillo AI, Tolon RM, Aranda A. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism. Oncogene\u20081998; 16: 1981\u201391.","DOI":"10.1038\/sj.onc.1200204"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/12\/5226\/2611551\/5226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/12\/5226\/2611551\/5226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:27:10Z","timestamp":1655429230000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/12\/5226\/549707\/Biological-Significance-of-Prolactin-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,15]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,6,15]]},"published-print":{"date-parts":[[2009,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4652","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22379273.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379273","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499202","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499202.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,15]]}}}